Generate a tailored SOP for Dr. Henry Daniell. Improve your application with a focused, well-structured draft.
Henry Daniell, Ph.D., is a Professor at the Perelman School of Medicine, University of Pennsylvania. His research focuses on oral delivery of human therapeutic proteins using bio-encapsulated plant cells. Dr. Daniell's work aims to develop low-cost alternatives for delivering biopharmaceuticals, especially in combating infectious and inherited diseases. His innovative approach includes using freeze-dried plant cells expressing therapeutic proteins, which can maintain stability and efficacy under room temperature conditions. He has published extensively on various vaccine antigens and therapeutic proteins, emphasizing their potential in providing mucosal immunity and treating conditions such as hemophilia and Alzheimer's disease. Collaboration with major organizations like the Gates Foundation further underlines the impact of his research in the field of translational medicine. His ongoing projects include exploring gene therapy and immune modulatory therapies, all designed to enhance the efficacy and accessibility of therapeutic proteins.
Wharton Doctoral programs cover fields like Finance, Marketing, Management, and Operations, Information and Decisions.